Matsuzaki T, Yokokura T, Azuma I
Cancer Immunol Immunother. 1985;20(1):18-22. doi: 10.1007/BF00199768.
The anti-tumour activity of Lactobacillus casei YIT 9018 (LC 9018) on Lewis lung carcinoma (3LL) in C57BL/6 mice and line-10 hepatoma in strain-2 guinea pigs was examined. Intravenous injection of LC 9018 was effective for inhibition of pulmonary metastases in C57BL/6 mice after s.c. inoculation with 3LL tumours. Intralesional (i.l.) injection of LC 9018 was also effective for both prolongation of the survival period and inhibition of pulmonary metastases in 3LL tumour-bearing mice. The combination treatment of i.l. and i.v. injections of LC 9018 before or after surgical excision of the primary tumour remarkably inhibited the pulmonary metastases after inoculation with 3LL tumour. Intralesional injection of LC 9018 was effective for regression of the established tumours of line-10 hepatoma inoculated i.d. and for induction of systemic tumour immunity in strain-2 guinea pigs.
研究了干酪乳杆菌YIT 9018(LC 9018)对C57BL/6小鼠Lewis肺癌(3LL)和2系豚鼠10号线肝癌的抗肿瘤活性。在皮下接种3LL肿瘤后,静脉注射LC 9018对抑制C57BL/6小鼠的肺转移有效。瘤内注射LC 9018对延长3LL荷瘤小鼠的生存期和抑制肺转移也有效。在原发性肿瘤手术切除之前或之后,瘤内和静脉注射LC 9018的联合治疗显著抑制了接种3LL肿瘤后的肺转移。瘤内注射LC 9018对接种于皮内的10号线肝癌的已建立肿瘤的消退以及对2系豚鼠的全身肿瘤免疫诱导有效。